DelShen Therapeutics - Toronto
DelShen Therapeutics is a medical marijuana company in Toronto committed to producing and supplying exclusive, safe, and effective strains of medical marijuana to the end-user. DelShen has the exclusive Canadian rights to the highest quality pharmaceutical grade medical marijuana strains developed in the Netherlands. The strains that Delshen’s experts have sourced come from Maripharm B.V., an ISO 9001 and GMP certified producer.
Additional Information
We understand that the medical community’s concerns pertaining to medical marijuana, its uses, and how to prescribe it to patients. Our team of medical professionals is here to discuss those concerns and point the medical community towards the large international body of knowledge that already exists regarding the indications that can be treated with medical marijuana and the results as compared with traditional pharmaceuticals.
Delshen represents a unique investment opportunity in a large population of would-be producers of medical marijuana. Be sure to register with us to be kept up to date in our progress as we make our way towards becoming a public company.
Product and Services
Boaz Wachtel operates one of only eight licensed producers in Israel and remains a medical marijuana pioneer, having initiated the Medical Grade Cannabis (“MGC”) efforts in Israel in 1996. Marcel de Wit is the Chairman of the non-profit organization – Maripharm B.V. – in the Netherlands, bringing his strains of MGC to Delshen.
Three of these strains were granted protection under the Community Plant Variety Office of the European Union, and have already been sold in the Netherlands and Israel for many years and thus have already been successfully tested and produced to pharmaceutical grades. Delshen holds a perpetual exclusive right to produce and sell the de Wit strains in North America. Maripharm is one of only two facilities with GMP and ISO 9001 certified operations in the world.
Coupled with the Company’s expertise is its facility and property in Northern Ontario. Delshen’s facility is 40,000 square feet of indoor growing space with on-property expansion capability on its 800 acre property, a former Ministry of Natural Resources operation. This facility is ideally suited for medical marijuana production and operations given its remoteness, access to power and the pre-existing grow operation facility. The Company’s government-built facility houses large scale production capability with reduced improvement costs.
Languages Spoken
English
Payment Options
Visa,Master Card,Cash,Check
